Insilico Medicine deploys the first bipedal humanoid AI scientist in fully-robotic drug discovery laboratory

bot1

Source: Insilico Medicine

Insilico Medicine, a clinical-stage biotechnology company pioneering generative AI for drug discovery and development, has announced the deployment of the first bipedal humanoid in its AI-powered fully-robotic drug discovery laboratory.

 Registered users, subscribers or members - SIGN IN

To continue reading this article

Membership

Included as a benefit

Members of Applied Microbiology International have unlimited access to The Microbiologist as a benefit of membership. Just sign in with your usual membership credentials.

I AM A MEMBER

Find out more about how to join.

 

Register

FREE

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy more free content each month.

REGISTER

 

Subscribe

3.75 per month / £35 annually

Get unlimited access to The Microbiologist.

SUBSCRIBE